Package 0074-1055-01

Brand: emrelis

Generic: telisotuzumab vedotin
NDC Package

Package Facts

Identity

Package NDC 0074-1055-01
Digits Only 0074105501
Product NDC 0074-1055
Product ID 0074-1055_998985bb-7cd1-4e80-bd08-8fc7c503f982
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1055-01) / 1 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2025-05-14
Brand emrelis
Generic telisotuzumab vedotin
Sample Package No

Linked Drug Pages (1)

EMRELIS ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "998985bb-7cd1-4e80-bd08-8fc7c503f982", "openfda": {"unii": ["976X9VXC3Z"], "rxcui": ["2714245", "2714251", "2714253", "2714255"], "spl_set_id": ["bc04f980-3957-4e35-ab81-8ec2ffe87215"], "manufacturer_name": ["AbbVie Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1055-01)  / 1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0074-1055-01", "marketing_start_date": "20250514"}], "brand_name": "EMRELIS", "product_id": "0074-1055_998985bb-7cd1-4e80-bd08-8fc7c503f982", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "product_ndc": "0074-1055", "generic_name": "Telisotuzumab Vedotin", "labeler_name": "AbbVie Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMRELIS", "active_ingredients": [{"name": "TELISOTUZUMAB VEDOTIN", "strength": "100 mg/mL"}], "application_number": "BLA761384", "marketing_category": "BLA", "marketing_start_date": "20250514", "listing_expiration_date": "20261231"}